BlackRock Amends EXACT SCIENCES CORP Stake as of Dec 31, 2023
Ticker: EXAS · Form: SC 13G/A · Filed: Jan 29, 2024 · CIK: 1124140
| Field | Detail |
|---|---|
| Company | Exact Sciences CORP (EXAS) |
| Form Type | SC 13G/A |
| Filed Date | Jan 29, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its passive stake in Exact Sciences; watch for market reaction.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 29, 2024, indicating a change in their ownership of EXACT SCIENCES CORP's common stock as of December 31, 2023. This amendment, number 2, updates their previous disclosures regarding their passive investment in the medical laboratories company. This matters to investors because BlackRock is a major institutional investor, and changes in their holdings can signal their confidence (or lack thereof) in the company's future prospects, potentially influencing other investors.
Why It Matters
This filing shows BlackRock's updated position in Exact Sciences, which can influence market perception and potentially the stock price due to their significant institutional presence.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate or significant risk to the company.
Analyst Insight
Investors should note BlackRock's continued, albeit updated, passive interest in Exact Sciences, but this filing alone doesn't provide enough detail to warrant immediate action. Further analysis of the specific share count changes (which are not provided in this excerpt) would be necessary to gauge the significance of this amendment.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person filing the SC 13G/A
- EXACT SCIENCES CORP (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 29, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G (Amendment No: 2)' sections.
Who is the reporting person in this filing?
The reporting person is BlackRock Inc., as indicated under the 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.' section.
What is the subject company whose securities are being reported?
The subject company is EXACT SCIENCES CORP, as stated under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: EXACT SCIENCES CORP' and 'Name of Issuer: EXACT SCIENCES CORP'.
What was the date of the event that required this filing?
The date of the event which required this filing was December 31, 2023, as specified under 'Date of Event Which Requires Filing of this Statement: December 31, 2023'.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of EXACT SCIENCES CORP is 30063P105, as listed under 'CUSIP Number: 30063P105'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 29, 2024 regarding EXACT SCIENCES CORP (EXAS).